Our work is currently funded through the following sources:

• Starting May 2024:

• • Open call from the Norwegian Cancer Society, Rosa sløfe (Pink Ribbon) scheme, for the project “Characterization of transcription factors that drive deregulation of the gene regulatory program through aberrant DNA methylation patterns in cancer cells”: NOK 7.5 millions over 4 years

---

• Since September 2021:

• • Open call on personalized breast cancer treatments from the Rosa sløfe (Pink Ribbon) campaign, Norwegian Cancer Society, for the project “Cis-regulatory signatures for improved identification and stratification of breast cancer subtypes”: NOK 4.999 millions over 4 years

---

• 2019-2024:
  • Young Research Talents grant from the Research Council of Norway for the project “Characterisation of cis-regulatory variations that dysregulate driver microRNAs in cancer”: NOK 7.352 millions over 3 years

---

• • Open Call grant from the Norwegian Cancer Society for the project “Characterisation of cis-regulatory variations that dysregulate driver microRNAs in cancer”: 1.968 millions over 4 years

---

• Since May 2016:
  • Research Council of Norway (project #187615), Helse-Sør Øst, and the University of Oslo through the Centre for Molecular Medicine Norway (NCMM): NOK 18M over 5 years as start-up package to launch the Computational Biology & Gene Regulation Group.